Abstract

Summary

This thesis presents a novel contact lens technology using plasmonic silver nanoparticles (AgNPs) to selectively block harmful blue-light wavelengths (400–450 nm) while transmitting beneficial wavelengths needed for circadian and pupillary functions. The approach offers a practical wearable solution for the 71 million contact lens users worldwide who currently have no commercially available UV and blue-light protective option.
Abstract

Key Findings

  • AgNPs were synthesized with tunable localized surface plasmon resonance (LSPR) peaks between 400–450 nm and full width at half maximum (FWHM) values of less than 45 nm, enabling precise selective blue-light filtering.
  • Silica-coated AgNPs integrated into commercial etafilcon contact lenses demonstrated blue-light filtering while maintaining transparency across visible wavelengths.
  • NP-integrated lenses showed stability after autoclaving, UV exposure, natural sunlight exposure, and room-temperature storage, supporting commercial viability.
  • No commercially available contact lenses currently offer both UV and blue-light protection despite over 71 million contact lens wearers worldwide.
Categories

Categories

Eye Health & Vision: The paper addresses retinal damage, AMD, and photophobia risks from blue light (HEV) and develops a contact lens solution to selectively filter harmful wavelengths.
The Science of Light: The work engages with spectral sensitivity of blue light wavelengths relevant to pupillary light reflex, melatonin regulation, and circadian rhythm, motivating selective rather than total blue-light filtering.
Sleep & Circadian Health: The thesis explicitly accounts for the role of specific blue-light wavelengths in melatonin regulation and circadian entrainment, designing filters to preserve these beneficial wavelengths.
Authors

Author(s)

H Krishnakumar
Publication Date

Publication Year

2018
View more publications